CasImg
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
产品纠错
CAS号:778270-11-4 | 英文名称:GNF-2
分子式 C18H13F3N4O2
分子量 374
EINECS号 200-256-5
MDL MFCD09265253
Smiles
InChIKey
乙二醇化学百科
基本信息
中文名称 3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺
英文名称 GNF-2
CAS号 778270-11-4
分子式 C18H13F3N4O2
分子量 374.32
EINECS号 200-256-5
物化性质
溶解度 H2O:<2毫克/毫升
形态 白色固体
颜色 米白色
安全信息
危险品标志 Xi
危险类别码 36/37/38
安全说明 26
WGK Germany 3
生产及用途
GNF-2 是一种具有高度选择性、变构的、非 ATP 竞争性 Bcr-Abl 抑制剂。 GNF-2 抑制 Ba/F3.p210 增殖, IC50 为 138 nM。

Bcr-Abl

GNF-2 selectively inhibits Bcr-abl-dependent cell proliferation. GNF-2 (0.005-10 μM; 48 hours) specifically inhibits the proliferation of the Bcr-abl-expressing cells with an IC 50 of 138 nM and not show any cytotoxic effects on the nontransformed cells at concentrations of up to 10 μM. GNF-2 (0.005-10 μM; 48 hours) causes a dose-dependent growth inhibition of the Bcr-abl-positive cell lines with IC 50 values of 273 nM (K562) and 268 nM (SUP-B15). GNF-2 (0.005-10 μM; 48 hours) inhibits E255V and Y253H mutant Bcr-abl cell growth (IC 50 values of 268 and 194 nM, respectively).
GNF-2 (1-10 μM; 48 hours) induces apoptosis of Bcr-abl-transformed cells.
GNF-2 (0.1-10 μM; 90 minutes) inhibits the cellular tyrosine phosphorylation of Bcr-abl in a dose-dependent manner with an IC 50 of 267 nM.

Cell Proliferation Assay

Cell Line: Ba/F3.p210, Ba/F3.p210 E255V and Ba/F3.p185 Y253H cells
Concentration: 0.005, 0.01, 0.1, 1, 10 μM
Incubation Time: 48 hours
Result: Inhibited Bcr-abl-transformed cells proliferation.

Apoptosis Analysis

Cell Line: Ba/F3.p210 and Ba/F3.p210 E255V cells
Concentration: 1, 10 μM
Incubation Time: 48 hours
Result: Increased number of Ba/F3.p210 cells undergoing apoptosis at 1 μM for 48 h.
Ba/F3.p210 E255V underwent apoptotic death after 48 h incubation in the presence of 1 μM or higher concentration.

Western Blot Analysis

Cell Line: Ba/F3.p210 and Ba/F3.p210 E255V cells
Concentration: 0.1, 1, 10 μM
Incubation Time: 90 minutes
Result: Decreased the autophosphorylation levels at a concentration of 1 μM and were barely detectable at 10 μM, whereas the level of total Bcr-abl remained unchanged.
Induced a significant decrease in the levels of p-Stat5 (at Y694) at 1 μM in Ba/F3.p210 and Ba/F3.p210 E255V cells.

GNF-2 (10 mg/kg; i.p. for 8 days) protects LPS (5 mg/kg) induced bone erosion in mice. GNF-2 protects the LPS induced bone loss and abrogates the LPS-induced decreases of bone volume/tissue volume (BV/TV) of LPS-treated mice.
GNF-2 prevents the LPS-induced increases of N.Oc/B.Pm, the percentage of Oc.S/BS, and the percentage of ES/BS.

Animal Model: Eight-week-old C57/BL6 mice were administered i.p. injections of LPS (5 mg/kg)
Dosage: 10 mg/kg
Administration: I.p. injections for 8 days; 1 day before and every day after the LPS injection
Result: Prevented inflammatory bone destruction in vivo.
上下游产品
上游产品共计:0个
下游产品共计:0个
产品供应商
GNF-2
询价
上海阿拉丁生化科技股份有限公司
2023-10-02

本网站展示的所有产品仅用于工业制造、技术研发、科学研究,所有产品非药品不可食用,依据国家相关法规及平台管理要求,购买相关危险物品应取得有效的资质、资格条件。 参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》 和《互联网危险物品信息发布管理规定》

Copyright © 2021-2025 chemhome123版权所有 |冀ICP备2024096099号- 1|冀公安备13042302000143号|互联网增值电信业务经营许可证:冀B2-20250121 |药品、 医疗器械互联网信息服务备案凭证备案号:(冀)-非经营性-2025-0099